The Ghana AIDS Commission has announced that it will introduce a new HIV preventive drug in 2026 as part of efforts to reduce infections, after the country recorded more than 15,000 new cases last year.
Director-General of the Commission, Dr. Prosper Akanbong, said the initiative is designed not only to strengthen prevention measures but also to boost local pharmaceutical capacity.
“As a country, we have already put the vaccine as a main component of our HIV prevention programme.
Initially, we will secure it from outside, but with the pharmacy organisations that you see here, they have positioned themselves to be able to produce the vaccines locally,” Dr. Akanbong stated during a briefing on Tuesday, September 30.
He added that discussions with pharmaceutical companies have already begun, with support from GIZ to ensure a sustainable rollout. “Together with GIZ, we are on track, and in the latter part of 2026 or the early part of 2027, we should be able to produce vaccines for Ghana,” he affirmed.
